[iPS cells for the generation of cartilage and for regenerative medicine and disease modeling of cartilage diseases].
Copyright policy )[iPS cells for the generation of cartilage and for regenerative medicine and disease modeling of cartilage diseases].
The development of induced pluripotent stem cells(iPSCs)has enabled the acquisition of patient-specific chondrocytes by converting somatic cells, such as dermal fibroblasts or blood cells, from patients to iPSCs and then differentiating them toward chondrocytes. We can further generate cartilage tissue from iPSC-derived chondrocytes. Studies on iPSC-derived chondrocytes/cartilage for the regeneration of articular cartilage injury are ongoing. These studies will in the future use autologous iPSCs and allogenic iPSCs from an iPSC stock prepared from donor cells. Drug discovery research for related diseases such as skeletal dysplasia is also being conducted.
- Kyoto University Japan
Induced Pluripotent Stem Cells, Animals, Humans, Cell Differentiation, Regenerative Medicine, Cartilage Diseases
Induced Pluripotent Stem Cells, Animals, Humans, Cell Differentiation, Regenerative Medicine, Cartilage Diseases
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!